Connect your AI

Mesa Laboratories MLAB Total Equity

Total Equity at other companies

3MMMM

$3.26B-26.9%

Thermo Fisher ScientificTMO

$51.93B+5.2%

DanaherDHR

$52.95B+4.1%

STERISSTE

$7.18B+8.8%

Bio-Rad LaboratoriesBIO

$6.85B+2.6%

Charles River LaboratoriesCRL

$2.94B-7.9%

Other financials

Income statement

Revenue$63.7M+2.6%

Gross profit$31.2M-0.5%

Operating income-$664.0K+85.5%

Net income$3.6M+317%

EPS (diluted)-$0.10+63.0%

Balance sheet

Cash & equivalents$26.9M-1.4%

Total debt$78.7M-53.1%

Total assets$427.7M-1.3%

Cash flow

Operating cash flow$14.0M+10.2%

CapEx$417.0K-44.9%

Free cash flow$13.5M+13.7%

Valuation

Market cap$542.27M+3.7%

Enterprise value$594.05M-10.4%

P/S2.2×0.0×

Profitability

Gross margin56.8%—

Operating margin2.3%—

Net margin1.5%+0.8pp

FCF margin15.9%-1.8pp

Returns & leverage

Return on equity2.2%+1.1pp

Debt / equity0.4×-0.6×

Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Mesa Laboratories's total equity?: Mesa Laboratories (MLAB) reported total equity of $186.25M in Q1 2026.
How has Mesa Laboratories's total equity changed year-over-year?: Mesa Laboratories's total equity increased by 16.5% year-over-year, from $159.83M to $186.25M.
What is the long-term trend for Mesa Laboratories's total equity?: Over 4 years (2021 to 2026), Mesa Laboratories's total equity has grown at a -17.7% compound annual growth rate (CAGR), from $406.23M to $186.25M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.